The Hypertrophic Cardiomyopathy (HCM) Program at University of Utah Health is one of the nation’s few programs for comprehensive HCM evaluation and management. Our multidisciplinary team works ...

Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This ...

—A thickened heart muscle raises the risk of ischemic stroke, but what happens when atrial fibrillation is thrown into the mix? A team of investigators in France made that question the focus of a ...

The common presenting symptoms among individuals with HCM include dyspnea, angina, and presyncope or syncope. Chest pain may occur at rest or be precipitated by exertion or, among those with LVOTO, a ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

Objective Current guidelines recommend precautionary disqualification from competitive sports in patients with hypertrophic cardiomyopathy (HCM). We assessed the incidence of cardiovascular events in ...

Colored x-ray shows enlargement of the left ventricle (yellow) in a patient with cardiomyopathy. Routine testing helps identify the disease and lowers the risk of sudden death, but prompt referral to ...